Brian Calimlim
0000-0002-6463-6433
AbbVie Inc.
1 paper found
Refreshing results…
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2)
Missing publications? Search for publications with a matching author name.